Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy - Wikidata - wikimedia - TriplyDB

Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy

Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy

http://www.wikidata.org/entity/Q40841949

about

Angiotensin receptors, autoimmunity, and preeclampsia Immunoadsorption therapy for patients with dilated cardiomyopathy and heart failure Antibodies in the pathogenesis of hypertension Targeting anti-beta-1-adrenergic receptor antibodies for dilated cardiomyopathy Novel receptor-derived cyclopeptides to treat heart failure caused by anti-β1-adrenoceptor antibodies in a human-analogous rat model Potential relevance of alpha(1)-adrenergic receptor autoantibodies in refractory hypertension Peripartum cardiomyopathy: challenges in diagnosis and management.Alpha1A-adrenergic receptor-directed autoimmunity induces left ventricular damage and diastolic dysfunction in rats.Endothelial dysfunction induced by antibodies against angiotensin AT1 receptor in immunized rats Autoantibodies to muscarinic acetylcholine receptors found in patients with primary biliary cirrhosis Congenital heart disease linked to maternal autoimmunity against cardiac myosin.Development of cardiomyopathy and atrial tachyarrhythmias associated with activating autoantibodies to beta-adrenergic and muscarinic receptors.Impact of human autoantibodies on β1-adrenergic receptor conformation, activity, and internalization.Antibodies to the α1-adrenergic receptor cause vascular impairments in rat brain as demonstrated by magnetic resonance angiography Autoantibodies and cardiovascular dysfunction: cause or consequence?β1-Adrenoceptor autoantibodies from DCM patients enhance the proliferation of T lymphocytes through the β1-AR/cAMP/PKA and p38 MAPK pathways.Recent insights into the role of autoimmunity in idiopathic dilated cardiomyopathy.The immunological basis of hypertension Autoantibodies against the β3-adrenoceptor protect from cardiac dysfunction in a rat model of pressure overload.Consequences of unlocking the cardiac myosin molecule in human myocarditis and cardiomyopathies Opposing cardiac effects of autoantibody activation of β-adrenergic and M2 muscarinic receptors in cardiac-related diseases.Decreased autophagy in rat heart induced by anti-β1-adrenergic receptor autoantibodies contributes to the decline in mitochondrial membrane potential Autoimmune hypertensive syndrome Cellular proliferative response to cardiac troponin-I in patients with idiopathic dilated cardiomyopathy.Receptor-activating autoantibodies and disease: preeclampsia and beyond.An acquired hypocalciuric hypercalcemia autoantibody induces allosteric transition among active human Ca-sensing receptor conformations.Anti-beta(1)-adrenergic receptor antibodies and heart failure: causation, not just correlation Autoimmune heart disease: role of sex hormones and autoantibodies in disease pathogenesis Decreased autophagy: a major factor for cardiomyocyte death induced by β1-adrenoceptor autoantibodies.Removal of pathogenic autoantibodies by immunoadsorption.Interferon-γ-mediated allograft rejection exacerbates cardiovascular disease of hyperlipidemic murine transplant recipients.Myocardial gene expression profiles and cardiodepressant autoantibodies predict response of patients with dilated cardiomyopathy to immunoadsorption therapy Adoptive passive transfer of rabbit beta1-adrenoceptor peptide immune cardiomyopathy into the Rag2-/- mouse: participation of the ER stress.Angiotensin II type 1 receptor antibodies and increased angiotensin II sensitivity in pregnant rats Recent clinical and translational research on pediatric myocarditis Protective cardiovascular and renal actions of vitamin D and estrogen Autoantibodies Specifically Against β1 Adrenergic Receptors and Adverse Clinical Outcome in Patients With Chronic Systolic Heart Failure in the β-Blocker Era: The Importance of Immunoglobulin G3 Subclass.How can we cure a heart "in flame"? A translational view on inflammation in heart failure.Darbepoetin alfa exerts a cardioprotective effect in autoimmune cardiomyopathy via reduction of ER stress and activation of the PI3K/Akt and STAT3 pathways.Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy.

P2860

Q24605647-0D79A34E-EBE0-4A2D-948F-C7DA137A09C6 Q24652847-32DBDEF5-1725-4F9F-A529-6F0522390B0A Q26828588-D6441088-7555-4B92-A03E-1BA5377F9B27 Q27000434-DBFCCA42-2EA5-4E63-A030-6B6D1FA97FB5 Q27315858-60E8F044-F467-4859-BFED-F23A52D41A5C Q28575913-5A2B22D7-7014-46C8-B7FD-52AA92624CC3 Q33363307-D0B5D5CC-5EFF-4BB1-A37B-37D30C5F1540 Q33535920-D07D5296-025F-47FF-AECA-96B5EED73AB0 Q33577570-299B40B5-6F79-4D98-BBD6-2DF319B57472 Q33720002-332201D2-1C60-43D5-BFF4-999431C8EA14 Q34035986-72BB153D-679E-48F1-AC2D-CA7E851D21CF Q34111376-FBA62623-1109-40DD-983B-7A83EAA83CF4 Q34315311-196C77F9-C634-4392-9054-5C740F2E6F7E Q34364148-AC926E7B-519A-4808-8C2C-334356FF3B47 Q34473885-2528B274-342E-4A45-92FA-892D4F2A0210 Q34541400-412FEB28-68EF-4005-AB4D-47AF2ED34124 Q34632155-6299EC66-AB4B-4D8C-9B1A-556451B759F3 Q34683745-EBA844B0-952B-43AA-908F-B476F8B7336C Q35023544-CD1F14BD-D357-445B-9C27-9A401E4BE9A0 Q35026108-4E2B7B6A-960E-4D48-A7C0-DA1377449184 Q35026111-39E791B2-89CC-43EF-A718-6733511AFD3D Q35053981-2D53EB2B-AADA-45D0-8C25-75648593CC72 Q35080102-68614FB0-F362-419F-95B8-1A169B075810 Q35492692-7AABD991-4420-4B25-85F2-299D16FC2DBE Q35707881-8625CC59-64A0-418D-ACE0-4A24E2FD63B6 Q35720141-71C789B8-7436-4671-8DCD-F79345D0633B Q35774994-82679E6B-C506-4AA5-AC32-55E5D6681401 Q35868721-D27574C4-81F4-4FE8-A0F3-2EB874BC36FD Q36022333-035F113D-9FD7-444D-9877-C5C7A090801A Q36242884-2AF7D6CA-3DB0-4C41-83D9-B21FF7707A6A Q36259538-AD250947-D67C-4021-BBD9-27E1060F9E45 Q36647124-C7AFF991-4B14-42D2-94AD-B4BBCCD81956 Q36665715-36DBF560-A931-436A-927F-C2A47C1B11D1 Q36683260-66B4D936-F1D5-4715-B816-1CA859D4DFDB Q36829646-2A5A0D83-B3E8-49C1-899F-0A77A286ADE1 Q36905627-337285DD-06C3-45B7-B51D-D57DED7794D8 Q36971570-A3AF6A13-9A60-45CC-98D4-EBCABBB85D98 Q37004826-06C5B692-8DB8-4442-96C1-2B636394B4C0 Q37008467-F7EE6358-2C30-4616-B053-6DD6EF7F1BC0 Q37051232-DB58D095-C098-4D3A-BF9F-640ECA3DF209

P2860

Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy

http://www.wikidata.org/entity/Q40841949

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

Direct evidence for a beta 1-a ...... opathic dilated cardiomyopathy

@en

type

label

Direct evidence for a beta 1-a ...... opathic dilated cardiomyopathy

@en

prefLabel

Direct evidence for a beta 1-a ...... opathic dilated cardiomyopathy

@en

P1433

Q40841949-1FEEE9D6-E3DA-4F22-8F93-F5357CCF41A5

P1476

Q40841949-E0EC8EDD-31C0-4901-BE17-2178B3FC60A3

P2093

Q40841949-0DF59ECF-56ED-43C6-A4D4-7507FCD53F4B

Q40841949-207A90B0-B5C4-4FE0-95AD-272C4953CB88

Q40841949-427E620D-FEB1-4832-8932-17898778B368

Q40841949-57E1145B-1DFF-4FCC-9FB0-BD0DE96F5A7C

Q40841949-64D14872-0A2B-4B0E-8D36-BBB2A326C436

Q40841949-CF14BDFA-647B-4511-89C4-02BD767752C7

P2860

Q40841949-00C2E93E-B4D6-408B-8A16-47AB280859DA

Q40841949-053DB8DE-4328-40EC-B76B-A42BCA143CF0

Q40841949-14EE3A67-7EB4-4558-A78A-ED1AD7BA239B

Q40841949-25057936-08A1-41AB-BAFD-6AEF204310B7

Q40841949-3D6591E8-141E-4774-B22C-C92F09978485

Q40841949-3DBAAF14-BD1F-4D51-9800-03FEB5F47A42

Q40841949-3FD98125-7610-414D-8FBE-6C4FFB618614

Q40841949-4F382A5A-D46C-4770-A746-4CE8577E7ABD

Q40841949-590B8C4E-9429-4963-ABFC-3ABE260B4813

Q40841949-611A2ECC-CEEC-4384-9900-D1E93D0B66C4

P304

Q40841949-80A740B9-C07F-4EA2-B631-F2186790BF4A

P31

Q40841949-13BEC94C-FEB2-433C-8F88-CE684BB07EC7

P356

Q40841949-4A21BA20-1C3F-443B-ADF0-FB9F5A33ED76

P407

Q40841949-29DF4081-15CB-4757-993D-887093F699D2

P433

Q40841949-3664B30F-BE7F-413E-80E4-A139121E8011

P478

Q40841949-06619ACF-9BDE-46B5-8E46-44BDB75A7937

P50

Q40841949-F5CB9DF0-7456-463F-9422-E88B134E9F76

P577

Q40841949-EBD47581-F36E-43DD-8803-73F8F8A12406

P698

Q40841949-55D0924E-B2DE-42F5-A245-5B2F66F34293

P932

Q40841949-F9CD9700-BD64-45D6-806A-4D858B4CC23B

P356

P1433

Journal of Clinical Investigation

P1476

Direct evidence for a beta 1-a ...... opathic dilated cardiomyopathy

@en

P2093

Christiane E Angermann

http://www.w3.org/2001/XMLSchema#string

Georg Ertl

http://www.w3.org/2001/XMLSchema#string

Lutz Hein

http://www.w3.org/2001/XMLSchema#string

Roland Jahns

http://www.w3.org/2001/XMLSchema#string

Sven Triebel

http://www.w3.org/2001/XMLSchema#string

Valérie Boivin

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning of the cDNA for the human beta 1-adrenergic receptor

Statistical methods for assessing agreement between two methods of clinical measurement

Chronic thyroiditis and autoimmunization

The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms

Defining criteria for autoimmune diseases (Witebsky's postulates revisited)

Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response

The Genetic Basis for Cardiomyopathy

Recent advances in cardiac beta(2)-adrenergic signal transduction.

Two functionally distinct alpha2-adrenergic receptors regulate sympathetic neurotransmission.

Infection, mimics, and autoimmune disease.

P304

1419-1429

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI200420149

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

113

http://www.w3.org/2001/XMLSchema#string

P50

P577

2004-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15146239

http://www.w3.org/2001/XMLSchema#string

P932

406525

http://www.w3.org/2001/XMLSchema#string